Targeted siRNA Delivery Using Lipid Nanoparticles
Efficient intracellular delivery of small-interfering ribonucleic acid (siRNA) to the target organ or tissues in the body is assumed as the main hurdle for a widespread use of siRNAs in the clinics. Solid lipid-based nanoparticles (SLNs) and derivatives can potentially fit this purpose by enabling t...
| Autor principal: | |
|---|---|
| Outros Autores: | , |
| Formato: | book |
| Idioma: | eng |
| Publicado em: |
2020
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/10316/91066 |
| País: | Portugal |
| Oai: | oai:estudogeral.sib.uc.pt:10316/91066 |